Trial Profile
A proof of concept trial to evaluate efficacy of palovarotene in dry eye disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Palovarotene (Primary)
- Indications Dry eyes
- Focus Proof of concept; Therapeutic Use
- 09 Oct 2018 New trial record
- 02 Oct 2018 According to a Clementia Pharmaceuticals media release, the trial is expected to start in 2019.